Wednesday, September 10, 2025
HomeTagsBiotechnology

Biotechnology

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...

Ionis Provides Update on Development Program Evaluating PCSK9 Antisense Medicine

Ionis Pharmaceuticals, Inc. announced that topline results from the Phase 2b SOLANO study in patients with hypercholesterolemia demonstrated that 60mg of ION449 (AZD8233) administered...

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis

Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of inflammatory disorders and autoimmune diseases, today announced...

Infixion Bioscience is Awarded Third NIH SBIR Phase 1 Grant

Infixion Bioscience, a pre-clinical drug discovery company focused on developing gene-targeted therapeutics for the rare genetic disorder Neurofibromatosis Type 1 (NF1), announced the awarding...

GMP Cell CDMO I Peace, Inc. In Collaboration With Universities Converted Human Dermal Fibroblasts Into Oligodendrocyte

Koji Tanabe of I Peace, Inc. and a researcher Hiroko Nobuta of the University of California, San Francisco (currently assistant professor at Rutgers University)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics